Albemarle Corporation announced its first quarter results with a 12% increase in net sales and a 17% increase in adjusted EBITDA. The company is progressing with its lithium expansion projects and expects to start approving Wave 3 expansion projects during the second quarter.
Net income of $95.7 million, or $0.84 per diluted share; Adjusted diluted EPS of $1.10, an increase of 10%
Net sales of $829.3 million, an increase of 12%
Adjusted EBITDA of $230.1 million an increase of 17%
Entered into a definitive agreement to sell the Fine Chemistry Services business to W. R. Grace & Co. for proceeds of approximately $570 million
Albemarle continues to expect its full year 2021 operating performance to improve modestly relative to full year 2020, assuming continued recovery from the global economic downturn.